Arthur H. Hayes Jr.
Arthur H. Hayes Jr. (born 1933) is an American physician and pharmacologist who served as the Commissioner of the Food and Drug Administration (FDA) from 1981 to 1983. He was appointed by President Ronald Reagan and played a significant role in the regulatory landscape of pharmaceuticals and medical devices during his tenure.
Early Life and Education[edit | edit source]
Arthur Hull Hayes Jr. was born in 1933. He pursued his undergraduate studies at Colgate University, where he earned a Bachelor of Arts degree. He then attended the Weill Cornell Medical College, obtaining his medical degree. Hayes completed his residency in internal medicine at the New York Hospital.
Career[edit | edit source]
Academic and Medical Career[edit | edit source]
Before his appointment to the FDA, Hayes had a distinguished career in academia and medicine. He served as a professor of medicine and pharmacology at the Pennsylvania State University College of Medicine and held various positions at the New York Medical College.
Commissioner of the FDA[edit | edit source]
In 1981, President Ronald Reagan appointed Hayes as the Commissioner of the FDA. During his tenure, Hayes was involved in several significant regulatory decisions and initiatives. He oversaw the approval of important drugs and medical devices and worked on policies to streamline the drug approval process.
One of the notable events during his tenure was the Tylenol crisis in 1982, where cyanide-laced Tylenol capsules led to several deaths. Hayes played a crucial role in managing the crisis and implementing new regulations to improve drug safety and packaging.
Post-FDA Career[edit | edit source]
After resigning from the FDA in 1983, Hayes joined the private sector. He held executive positions in various pharmaceutical companies, including EM Pharmaceuticals and Sandoz Pharmaceuticals.
Legacy[edit | edit source]
Arthur H. Hayes Jr.'s tenure at the FDA is remembered for his efforts to balance drug safety with the need for timely approval of new therapies. His leadership during the Tylenol crisis is often cited as a pivotal moment in the history of drug regulation in the United States.
See Also[edit | edit source]
- Food and Drug Administration
- Tylenol crisis
- Ronald Reagan
- Pharmacology
- Weill Cornell Medical College
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
- 1933 births
- Living people
- American pharmacologists
- Commissioners of the Food and Drug Administration
- Colgate University alumni
- Weill Cornell Medical College alumni
- New York Medical College faculty
- Pennsylvania State University faculty
- Reagan administration personnel
- American physicians
- Medicine stubs
- Encyclopedia
Contributors: Prab R. Tumpati, MD